R

Director Director DIN 08296420
DIN 08296420 First appointment Dec 2018 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Dec 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Renuca

Data last updated:

Renuca was a Director at Inventland Research Laboratories Private Limited (2018–2022) and Director at Inventland Pharmaceutical Private Limited (from 2019). The companies operate in Pharma.

DIN 08296420
Primary Designation Director
Industry Pharma
First Appointment 06 Dec 2018
Oldest Company Age 6 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director06 Dec 20182018₹1.29 Cr (FY 2024)Active
Director31 Dec 20192019Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Inventland Pharmaceutical Private Limited
Inventland Research Laboratories Private Limited
Premium access

Shareholding and investment profile for Renuca

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Renuca

Renuca was first appointed on 06 Dec 2018 as Director at Inventland Research Laboratories Private Limited. The most recent appointment on record is 31 Dec 2019 at Inventland Pharmaceutical Private Limited.

Renuca held 2 earlier board appointments: Inventland Research Laboratories Private Limited (Director, 06 Dec 2018 to 14 Jul 2022); Inventland Pharmaceutical Private Limited (Director, from 31 Dec 2019).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available